Kurt G. Briscoe
direct dial: (917) 369-8880
PDF of Biography
Areas of Practice
- U.S. Court of Appeals
- Federal Circuit
- U.S. Patent and Trademark Office
- University of Maryland School of Law
- J.D., 1986
- University of Maryland
- B.S., 1982
- American Intellectual Property Lawyers Association
- New York Intellectual Property Law Association
- Maryland State Bar Association
- The New Jersey Center for Biomaterials
- "Now You See It, Now You Don't: Making Certain Anticipation Rejections Magically Disappear by Showing Unexpected Results," NM&M Thinking About Patents, April 2013
- "Final Rules For Implementing The America Invents Act (AIA)," NM&M Intellectual Property Law Alert, September 2012
- "Therasense v. Becton Dickinson: Inequitable Conduct Defense Eviscerated," Intellectual Property Law Alert, June 2011
- "Depth and Diversity Enhance IP Practice at Norris, McLaughlin & Marcus ," The Metropolitan Corporate Counsel, June 2004
- "Recent Decision of the United States Supreme Court Clarifying the Application of the Doctrine of Equivalents," Intellectual Property Law Alert, July 2002
- "AIA Strategies." Germany, May 6-12, 2012
- "Are Genes Patentable?," Yorktown Bar Association, May 25, 2011
- "Software and Business Method Patents: A Defensive & Offensive Strategy," Minority Corporate Counsel Association (MCCA) 5th Annual CLE Expo, March 15-17, 2006
Kurt G. Briscoe, a member of the firm’s New York City office, devotes his practice to patent, trademark, and other intellectual property matters.
Kurt has over 25 years of experience in intellectual property law, including five years, from 1983 to 1988, as an examiner in the United States Patent and Trademark Office. Most of Kurt’s practice, including his experience as a patent examiner, has been in the field of pharmaceuticals and biotechnology.
Kurt regularly represents domestic and international companies in connection with the preparation and prosecution of patent and trademark applications. In addition, he regularly negotiates licensing and nondisclosure agreements for these clients. Kurt provides experienced worldwide IP portfolio management, including strategic, freedom-to-operate, invalidity, and infringement opinions. Kurt also performs due diligence for clients prior to their acquisition of patents and trademarks to reveal any patent validity or enforceability problems, or patent prosecution events that impact patent claim scope.
Kurt is also experienced in trade secret law. He assists clients in drafting and reviewing legal agreements related to unpatented products, inventions, processes, and other forms of proprietary information.
In addition to the pharmaceuticals and biotechnology industries, Kurt has extensive experience in the chemical, medical and dental device, and adhesive technology industries.